Gatifloxacin

89 interactions 5 explained in plain English

Also sold as: Zymaxid

Medically reviewed by Dr. Brian Staiger, PharmD, BCPS · Updated Jul 4, 2026 · Editorial policy · Data sources

Sources: FDA prescribing information (Structured Product Labeling), the published literature cited in each entry, DDInter 2.0 (a major open-access drug-interaction database), and legacy DrugBank interaction data distributed by the NIH's RxNav service (decommissioned in 2024) — analyzed and reviewed by our pharmacist team. How we build this library →

Most serious with: Dolasetron Injection Loperamide Anagrelide Moxifloxacin Ophthalmic Disopyramide Fostemsavir

86 Major 3 Moderate

All (89) Major (86) Moderate (3)

Major

Gatifloxacin Amitriptyline Elavil Explained An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Sertraline Explained An increased risk of QT interval prolongation Details Gatifloxacin Buprenorphine Belbuca Explained An increased risk of QT interval prolongation Details Gatifloxacin Relugolix Orgovyx Explained Increased risk of QT interval prolongation Details Gatifloxacin Acarbose Prandase® Explained Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Amisulpride Injection Barhemsys Increased risk of serious ventricular arrhythmias such as torsades de pointes Details Gatifloxacin Arsenic Trioxide Trisenox An increased risk of QT interval prolongation Details Gatifloxacin Aripiprazole Injection Abilify An increased risk of QT interval prolongation Details Gatifloxacin Arsenic Trioxide Injection Trisenox An increased risk of QT interval prolongation Details Gatifloxacin Asenapine Transdermal Patch Secuado Increased risk of QT interval prolongation Details Gatifloxacin Azithromycin AzaSite An increased risk of QT interval prolongation Details Gatifloxacin Alfuzosin UroXatral An increased risk of QT interval prolongation Details Gatifloxacin Alogliptin Nesina Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Anagrelide Agrylin Increased anagrelide exposure and increased risk of QT interval prolongation Details Gatifloxacin Bedaquiline Sirturo Increased risk of QT interval prolongation Details Gatifloxacin Budesonide Entocort An increased risk of tendon rupture Details Gatifloxacin Budesonide Nasal Spray Rhinocort An increased risk of tendon rupture Details Gatifloxacin Budesonide Oral Inhalation Pulmicort An increased risk of tendon rupture Details Gatifloxacin Canagliflozin Invokana Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Chloroquine Aralen® An increased risk of QT interval prolongation Details Gatifloxacin Dapagliflozin Farxiga Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Dasatinib Phyrago An increased risk of QT interval prolongation Details Gatifloxacin Deflazacort Emflaza An increased risk of tendon rupture Details Gatifloxacin Degarelix Injection Firmagon Increased risk of QT interval prolongation Details Gatifloxacin Deutetrabenazine Austedo An increased risk of QT interval prolongation Details Gatifloxacin Dexamethasone Injection Decadron An increased risk of tendon rupture Details Gatifloxacin Dexamethasone Ophthalmic Dexacidin® (as a combination product containing Dexamethasone, Neomycin, Polymyxin B) An increased risk of tendon rupture Details Gatifloxacin Disopyramide Norpace An increased risk of QT interval prolongation Details Gatifloxacin Dofetilide Tikosyn An increased risk of cardiotoxicity (QT prolongation, torsades de pointes, cardiac arrest) Details Gatifloxacin Dolasetron Anzemet An increased risk of QT interval prolongation Details Gatifloxacin Dolasetron Injection Anzemet An increased risk of QT interval prolongation Details Gatifloxacin Dulaglutide Injection Trulicity Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Empagliflozin Glyxambi® (as a combination product containing Empagliflozin and Linagliptin) Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Encorafenib Braftovi Increased risk of QT interval prolongation Details Gatifloxacin Entrectinib Rozlytrek An increased risk of QT interval prolongation Details Gatifloxacin Ertugliflozin Steglatro Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Exenatide Injection Bydureon Changes in blood glucose and increased risk of hypoglycemia or hyperglycemia Details Gatifloxacin Flecainide Tambocor® An increased risk of QT interval prolongation Details Gatifloxacin Fludrocortisone Acetate Florinef® An increased risk of tendon rupture Details Gatifloxacin Foscarnet Injection Foscavir Increased risk of QT interval prolongation Details

Check another drug

Still have questions about this combination?

Every question gets a real answer from a licensed pharmacist — free, and usually within a day.

Ask the pharmacist

Educational information only, not medical advice. Always confirm interactions with your pharmacist or prescriber before making any change to your medications.